![(2Z)-{1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-sulfanylpiperidin-3-ylidene}ethanoic acid](https://static.cymitquimica.com/cas-image/391439-2z-1-2-cyclopropyl-1-2-fluorophenyl-2-oxoethyl-4-sulfanylpiperidin-3-ylidene-ethanoic-acid.png)
CAS: 239466-74-1 - (2Z)-{1-[2-cyclopropyl-1-(2-fluorophenyl)-2-oxoethyl]-4-sulfanylpiperidin-3-ylidene}ethanoic acid
Formula:C18H20FNO3S
InChI:InChI=1/C18H20FNO3S/c19-14-4-2-1-3-13(14)17(18(23)11-5-6-11)20-8-7-15(24)12(10-20)9-16(21)22/h1-4,9,11,15,17,24H,5-8,10H2,(H,21,22)/b12-9-
Prasugrel Impurity 27 (Mixture of Diastereomers)
CAS:239466-74-1
Formula:
C18H20FNO3S
Color and Shape:
White To Off-White Solid
Molecular weight:
349.42
Ref: 4Z-P-3966
| 5mg | 1,687.00 € | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
Prasugrel Impurity 27-d4 (Mixture of Diastereomers)
CAS:239466-74-1
Formula:
C18H16D4FNO3S
Color and Shape:
White To Off-White Solid
Molecular weight:
353.44
Ref: 4Z-P-3967
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Thursday 2 Jan 2025
trans R-138727, (Prasugrel Metabolite) - >90%(Mixture of Diastereomers)
Controlled ProductCAS:239466-74-1
Formula:
C18H20FNO3S
Color and Shape:
White To Light Yellow
Molecular weight:
349.42
Ref: TR-R070195
| 1mg | 277.00 € | ||
| 5mg | 1,179.00 € | ||
| 10mg | 1,998.00 € |
Estimated delivery in United States, on Friday 10 Jan 2025
trans R-138727-d4, (Prasugrel-d4 Metabolite)(Mixture of Diastereomers)
Controlled ProductCAS:239466-74-1
Formula:
C18D4H16FNO3S
Color and Shape:
Neat
Molecular weight:
353.444
Ref: TR-R070202
| 5mg | 15,186.00 € |
Estimated delivery in United States, on Monday 10 Feb 2025
Prasugrel metabolite
CAS:239466-74-1
Prasugrel is a prodrug that is metabolized to its active form, the prasugrel metabolite (PMS), …
Formula:
C18H20FNO3S
Purity:
Min. 95%
Molecular weight:
349.42 g/mol
Ref: 3D-FP39260
| 5mg | Discontinued | Request information |
